ADRB3 and renal cell carcinoma: Therefore, we aimed to evaluate whether the progression of ccRCC is affected by a β3-AR agonist, and to explore its potential role in tumor initiation using metastatic orthotopic murine RCC models through the perspective of regulation of TIME and PAT browning.